When she’s not busy trying to rid the world of cellulite as CEO of Elemé Medical, Inc., Nancy Briefs finds time for her duties on the board of the Medical Device Manufacturers Assn., a national advocacy group for med-tech companies.
As a result, Briefs has a unique perspective on the challenges companies face in this market.
Elemé had its commercial launch in 2009, during the darkest days of the recession, and has fought to build market share in an economy that’s forcing people to cut back on non-essentials.
MassDevice New Year’s Special P/review
- P/review: Introduction
- P/review: Paul LaViolette
- P/review: Stephen Ubl
- P/review: David Lucchino
- P/review: Euan Thomson
- P/review: Brian DeChristopher
- P/review: Christopher Delporte
- P/review: Don Hardison
- P/review: Brent Hudson
- P/review: Hamid Tatabaie
- P/review: Patrick Dentinger
- P/review: Nancy Briefs
- P/review: Brian Concannon
- P/review: Ryan Howard
- P/review: Ed Berger
- P/review: Top stories of 2010
Shields, who has also been keeping a close eye on changes going on in Washington, stopped long enough to tell us what’s on her mind as the calendar clicks over to 2011.
“I think the biggest priority for Eleme is raising additional capital to support development of our next generation technology,” she said. “For the industry it is the pending FDA regulatory reform and what impact it will have on American medical device firms ability to commercialize new products.”
“For the industry it is the pending FDA regulatory reform and what impact it will have on American medical device firms ability to commercialize new products.”